Enanta Pharmaceuticals Inc.

ENTA

Held by 1 specialist biotech fund

High short interest · No specialist buying

Fund Holdings

Nov 14, 2025

$9.6M

1 fund

Feb 17, 2026

$0

0 funds

-100% total institutional value over 2 quarters

High short interest

Short Shares

2.16M

Change

-4.9%

Days to Cover

11.2

% of Float

8.9%

Settlement

Mar 13, 2026

Short interest over 2 periods

No catalysts tracked.

Shares: 800,000Value: $9.6M

Shares: 800,000Value: $9.6M

No insider signals tracked.

Track specialist biotech funds, insider signals, and AI analysis

Or get the free weekly brief: